Form 4: IGM Biosciences CEO Fred Schwarzer Sells Shares to Cover Tax Obligations

IGM Biosciences CEO Fred Schwarzer sold shares of common stock on March 13 and 14, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Fred Schwarzer, CEO and President of IGM Biosciences, sold shares of the company's common stock on March 13 and 14, 2024.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On March 13, 2024, 4,765 shares were sold at a weighted average price of $9.8752.
• On March 14, 2024, 4,182 shares were sold at a weighted average price of $10.1705.
• Following these transactions, Schwarzer directly owns 216,651 shares and indirectly owns 196,718 shares through the Schwarzer Family Trust.
• The sales were executed in multiple trades at varying prices, with the reported prices reflecting weighted averages.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock sales for tax purposes. It doesn't convey strong positive or negative sentiment about the company's prospects.

Industry Context

Insider sales are a common occurrence, especially to cover tax obligations related to equity compensation. The market typically analyzes these sales in the context of the overall company performance and insider sentiment.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholders due to slight dilution.
• The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates